Implications for Practice: Despite national cancer reforms, unmet supportive care needs persist. The findings from this study may be central in the re-design of future services to optimize men's quality of life and satisfaction with care. Clinicians are encouraged to use these finding to help them optimize care delivery and individual quality of life.
n Introduction Currently, 250 000 men are affected by prostate cancer in the United Kingdom. 1 The data identify that more men receive a diagnosis of prostate cancer at an early stage (59% received a diagnosis at stage I or II) than at an advanced stage (41% received a diagnosis at stage III or IV). Moreover, approximately 1 in 5 men will have metastases at diagnosis (stage IV). 2 Men with locally advanced or metastatic prostate cancer where curative intent is no longer the treatment goal face distinct challenges in contrast to men with localized prostate cancer. 3 Male hormones, specifically testosterone, fuel the growth of prostate cancer. By reducing the amount and activity of testosterone, the growth of advanced prostate cancer is slowed and controlled but not cured. Hormone therapy is the main treatment for men with disseminated prostate cancer that is easily administered treatment, but it is not without side effects. 4 Men undergoing hormone therapy may experience the following psychological effects: mood disturbance, cognitive impairment, difficulties with self-image and masculinities; physical effects such as hot flushes, osteoporosis, spinal cord compression, fatigue, sexual dysfunction, and changes in muscle mass; and adiposity. 5 Similar to men with localized prostate cancer, men with advanced stage disease report higher levels of psychological distress, poorer quality of life, and greater symptom burden. 6 There is evidence acknowledging that men affected by prostate cancer have reported a range of needs 7, 8 that include informational needs, 9, 10 self-management of urological symptoms, 11 psychological problems, 12 and sexual needs. 4 ,13Y15 Supportive care is a person-centered approach to the provision of the necessary services for those living with or affected by cancer to meet their informational, spiritual, emotional, social, or physical needs during diagnosis, treatment, or follow-up phases including issues of health promotion and prevention, survivorship, palliation, and bereavement. 9, 16, 17 In the United Kingdom and internationally, the drive to find alternative methods of service delivery in this patient group are demonstrated by a range of studies. 18Y20 Because the prevalence of prostate cancer increases, alternative models of follow-up care are now being considered. 21 Recently, a systematic review of the evidence 22 highlighted the substantial effect of cancer and treatment on long-term health and quality of life. This posed the question about the most appropriate configuration of health care services and follow-up models of care. However, patients' perspectives and their experiences of supportive care are not well articulated within the existing evidence base. 23 Previous research has mainly focused on symptom experience and quality of life using both qualitative and quantitative approaches 6 ,24Y26 but has not specifically addressed unmet supportive care needs experienced within existing health services. Two recent systematic reviews 8, 27 concluded that there is a dearth of research to help guide clinicians on the supportive care needs of men undergoing hormone therapy and to optimize a personcentered holistic model of shared care for these men. We need further understanding as to why unmet supportive care needs persist in current care delivery in the United Kingdom, despite national cancer reforms to improve and optimize supportive care 28 for people living with prostate cancer. This is the first study to address the question ''What are the experiences of unmet supportive care needs in men affected by prostate cancer on hormone treatment in current healthcare?'' Study Design, Sample, and Methods
Institutional ethical approval (Caldiott/CSAppGN021211) was granted for this mixed methods study and was conducted in line with the consolidated criteria for reporting qualitative research. 29 The participants were recruited into the study based on the following inclusion criteria: (1) received a diagnosis of QT3 prostate Cancer or worse on hormone therapy, (2) adults (Q18years), (3) deemed physically/psychologically well to participate in the study by a member of the clinical multidisciplinary team, and (4) able to understand and communicate in the English language. Exclusion criteria were (1) patients unable to meet the inclusion criteria and (2) unable to provide written informed consent. The participants were recruited from a main cancer center in Scotland, United Kingdom.
A total of 35 men were invited; of which, 31 men consented to participate (88.6% response rate). Reasons for nonparticipation included feeling unwell as a result of treatment (n=2) and not interested (n=2). Patients (n=31) were sent a postal questionnaire by a member of their healthcare team and a stamped, addressed return envelope to inform the development of the interview topic guide for the qualitative component of this study.
n Variables Age, socioeconomic status (Scottish Index of Multiple Deprivation), cancer stage, prostate-specific antigen, and comorbidities were collected from case records. psychological needs, health system, physical and daily living, patient care and support, and sexuality. Reliability and validity of this instrument has been previously demonstrated, including with men on treatment for prostate cancer. 30, 31 Self-Management Self-Efficacy Scale
The Self-Efficacy Scale 32 provides an assessment of participants' belief and confidence to perform their self-management. Self-efficacy is a general term used to describe the belief that one can perform a novel or a difficult task or cope with adversity in various domains of human functioning. Reliability and validity of the general Self-Efficacy Scale has been demonstrated previously. 32 No normative data exist for this questionnaire.
EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE PROSTATE MODULE
The EORTC quality of life (QLQ C30) 33 and the prostate module (PR25) 34 comprise an integrated measurement system for Health Related Quality of Life (HRQoL) in cancer participants. Reliability and validity of the QLQ C30 33 and the PR25 34 have been demonstrated previously. Normative data are available for the QLQ C30 detailed in Table 1 for a heterogeneous sample (all prostate cancer stages), but no normative data are available for the PR25.
n Interview Design
The data were collected between January and May 2015. Exploratory semi-structured interviews were conducted using a topic guide informed by existing literature, the original research question, the questionnaire data from the 31 respondents, and the classification of supportive care needs 8, 9, 16, 17 (Table 2 ). Purposive sampling of the interviews (n=8) ensured maximum variation by patients' age (range, 67Y84 years), socioeconomic background (Scottish Index of Multiple Deprivation, 1Y5), time since diagnosis (April 2013YNovember 2014), and prevalence of the number of existing comorbidities (range, 0Y5). The study sample was designed to enable the researchers to explore some diversity in men's experiences of follow-up care. The study's multidisciplinary team included a Senior Prostate Cancer Specialist Nurse and Professor of Surgical uro-oncology consultant urological surgeon with special interest in prostate cancer who commented on emergent themes and areas that might be worthy to probe in subsequent interviews. The common themes were continually reviewed. Field notes were written immediately after the interviews to record any unrecorded conversations before and after the ''formal'' interview.
n Description of Interview All interviews were conducted in the participants' homes by Senior Prostate Cancer Specialist Nurse, who was responsible for the overall research process. Interviews were digitally recorded with the patient's written consent. The interviews began with an open-ended, nondirective question to encourage the men to speak about their experiences of their follow-up care. Open-ended probe questions were also used to elicit greater detail of experiences shared by participants ( Table 3) .
Analysis of Qualitative and Quantitative Data
The in-depth, semistructured interviews lasted 40 to 90 minutes. Recordings were transcribed verbatim and cross-checked for accuracy, and identifying information were removed. Senior Prostate Cancer Specialist Nurse coded all of the interviews, and coding was subsequently verified by the professor of surgical uro-oncology/consultant urological surgeon who has special interest in prostate cancer, ensuring a close match. Framework analysis 35 was used to examine commonalities and differences within and between the transcripts. Broad themes were identified first and then broken down in to sub-themes. An electronic matrix display (in Microsoft Excel; Microsoft Office Excel, Scotland) was used to keep a transparent account of how themes were derived, and this display included original links to the data. Triangulation strategies included comparison of the study results with those in previous studies conducted in the patient population 9, 12, 35 and with the data collected from the questionnaire survey (n=31). The questionnaire data were analyzed using traditional exploratory analysis and descriptive statistics 36 in SPSS version 21 (IBM Corp, Armonk, New York).
n Results
A total of 31 men participated in the cross-sectional survey (Table 4) , and 8 men took part in the in-depth interviews ( Table 5 ). The mean age of the study participants was 80.1 (SD, 6.9) years. Men reported lower levels of self-efficacy, 3.3 (SD, .9), when compared with other published data 37 that may have influenced the experience of unmet supportive care needs in this patient population. Questionnaire data identified that men reported a range of symptoms (urinary, fatigue, pain, and bowel) that reduced quality of life (Table 4) . When compared with normative data (Table 1) , the current study population reported lower functional outcomes that included physical function, role function, cognitive function, but higher emotional and cognitive function. Men reported higher levels of diarrhea but fewer symptoms on all other scales when compared with normative data. Despite being a relatively small sample of men (n=31), men reported a range of unmet supportive care needs related to the fear of cancer spreading (n=13, 41.9%), lack of energy/ tiredness (n=10, 32.3%), worry that the results of treatment are beyond his control (n=9, 29%), uncertainty of the future (n=9, 29%), and being given inadequate information (n=9, 29%) ( Table 6 ). Interestingly, men further articulated these specific unmet needs and shared their experiences in greater depth in the qualitative findings.
Psychological/Emotional Consequence
Men spoke about uncertainty, worry, and emotional needs of living with advanced prostate cancer and the effect at diagnosis: This was a similar experience to another man: I thought they were going to do something with the catheter, I didn't realize I was getting the results, so of course I got the results on my own, didn't take Another man spoke about his initial experience of bone pain:
The pain was terrific in my back, and then I had to go onto the patches, but it is controlled now. I needed to keep asking my General Practitioner (GP) for help, I couldn't even get out of my bed, and it was a problem as how could I even get to the toilet? I mean, I felt helpless with this pain and affected my wife too seeing me like this. ''To be honest with getting older I have less urges to chase women around, and he (consultant) says that will happen with this treatment, you just lose the urge for a bit of dalliance.'' Interviewer: Does this impact upon your quality of life? ''Well, yes it does particularly while on holidays Men also spoke about changes in their masculinity and body image:
'' IIt, like the testes, I mean do they go smaller?'' Interviewer: Have you noticed this? ''Oh yes, the testes are definitely down, shrunken wee [little] things now. I don't know why they just don't take them out.'' (No. 6, 79 years)
PRACTICALITY OF LIVING WITH PROSTATE CANCER AND TREATMENT
A common need across men was difficulties in attending outpatient clinics due to reduced mobility and difficulties with hospital transportation.
''It is a struggle I I have got a niece, and she is affa [awful] obliging; she took me, and then my neighbor took me, because we have got a car that I am not able to drive anymore; it is sitting in the garage, and it was a new car. I was advised not to drive anymore because the bones are so, in case I have to break suddenly with my bones being so weak. I do miss the car. It was a long day with patient transport, and I was up to 99 [very anxious], with nobody to take me there, and no lunch; my wife could not come in the patient transport either with the insurance or something.'' (No. 7, 84 years)
Other practical needs men spoke about were in relation to getting holiday insurance (travel insurance for going on vacation) as consequence of having prostate cancer:
''I want to get away on holiday again, you know, but I find it hard to get insurance, that is the trouble.'' Interviewer: Can you tell me more about what makes it challenging? ''Age is, for a start, and then you say I have got prostate cancer, and then they say oh, 'I can't cover you for that, or it will cost you 3000 quid [pounds] you know' I It is a substantial amount of money, and I think that they just didn't want to cover me, you know, at that price. Another man also expressed existential concerns:
It was a shock, I don't know how long you have prostate cancer for before it affects you and you die? I never thought about dying before, even though when you were getting into your 80s; you know, you push it toward the back of your mind. But eh, now I have to bring it forward, and life goes on whether you are there or not. (No. 6, 79 years)
n Lack of Health System/Information
Many of the men reported a lack of understanding and information about prostate cancer, diagnosis, and treatment. Men were given various levels of written information in some basic leaflets, and others were provided with more comprehensive information booklets. There is a need to tailor information to each individual man, because according to 1 man, All that I would say is when bad news is being given, it is so important to have a compassionate consultant to impart that information, but also back up nurses who can take them away from there to understand the information, and take them somewhere quiet to talk them through em. Because very often when you get that news, you can't hear everything; all that you hear is that you have cancer, and it's spread, and it's here, there and there, and wherever. You don't hear anything else, and having a nurse specially trained and has empathy, I would definitely suggest that is something to look at. I think for other people, it has to be addressed, no empathy. (No. 3, 77 years)
Other men spoke about a lack of holistic supportive care during their clinical consultation:
''I already get that blood sample, and they check it, and he tells me if it is up or down; last time, he said it was up a bit, I don't know what up is, but something, and basically that is it.'' Interviewer: How long do you see your consultant for? ''Oh, about 10minutes at the most; it takes me longer to walk in and out to get the taxi, rather than the time I am in there.'' Interviewer: What else do they discuss, can you tell me more? ''They honestly don't really discuss anything more; he checks the blood and then see you in 3months or so.'' (No. 4, 81 years) n Improvements in Service Delivery
The research team asked the men about their current experience of care and suggestions for improvement. For the most part, men were overall satisfied with their care, but there were a number of suggestions in relation to (a) ensuring that the clinical team has empathy and compassion; (b) tailored informational support including self-management advice that is easy to understand; (c) having greater access to cancer nursing specialists: ''Well I don't know if you have a specialist nurse to inform and keep in touch with you, even just a quick phone call to ask how are you, if you don't need and you are fine, but at least to have the option. I think that would be good, and you know you are not on your own.'' (No. 5, 67 years); (d) ensuring accurate communication between primary and secondary care: ''I really just want to make sure that my GP is told everything that is going on.'' (No. 8, 74 years); and (e) offering holistic person-centered supportive care as identified across a number of subthemes: physical needs, psychological/emotional needs, intimacy/sexual needs, practice needs, health system/informational needs, existential needs, and patient/clinician communication.
n Discussion
This mixed methods study aimed to understand the diverse supportive care needs of men who received a diagnosis of prostate cancer and was treated with hormone therapy within the context of current service delivery. This study is timely to understand any existing unmet needs of people affected by cancer, given our national and international cancer reforms. The findings identified that men experienced a range of unmet supportive care needs and reduced scores of self-management self-efficacy. 37 These findings may serve to target translational research in the future, with clear implications for clinical practice. Men affected by prostate cancer on hormone therapy have areas of high unmet needs, and this was particularly relevant to men's psychological and existential needs around the time of diagnosis and into treatment. Men spoke about uncertainty for the future, feelings of death and dying, and fear of the cancer spreading, which is a consistent experience of living with cancer as a chronic illness. 38 Importantly, the findings from this study have identified that the current care delivery is failing to provide a holistic person-centered model of supportive care, with some men articulating a lack of empathy, compassion, and access to specialist cancer nurses, and these findings are in keeping with existing evidence. 8, 15 Moreover, men reported a range of unmet needs in relation to physical, intimacy/sexual, practical, and health system/informational needs; existential concerns; emotional and psychological needs; and patient/clinician communication. 8, 10, 39 This study makes an important contribution to the understanding of the role of supportive care in optimizing quality of life, reducing distress, and improving overall satisfaction with the care. Men articulated the need for future delivery of care to have involvement and access to cancer specialist nurses to address areas of unmet needs, a need also identified elsewhere. 40 Nurse-led care and coordination roles have been promoted as an important component of cancer services, 41 and nurses are already providing follow-up clinics for patients with prostate cancer as part of the multidisciplinary approach, as suggested in clinical guidelines 21 to provide continuity of care for patients and their family; provide information, education, and support; be accessible to patients and their family; and to release consultant time. 42, 43 This study provides comprehensive data to understand the complex patient-specific multifaceted unmet needs that are experienced in current care provision in this particular patient group. These findings are an essential precursor to inform the appropriate configuration of future service delivery. It is commonly asserted that the patients' perspective should inform clinical decision making, and direct collection of outcome data from the patient should be incorporated in clinical practice.
44Y47
Patient-reported outcome measures are described as standardized, validated questionnaires that are completed by patients to measure their perceptions of their needs, quality of life, and symptom burden. 44 Emergent evidence supports the routine use of patient-reported outcome measures to help drive changes in how healthcare is organized and delivered but at the ''individual patient perspective'' to empower men to share and identify areas of unmet needs during clinical consultation. Enabling healthcare providers, such as cancer specialist nurses with the necessary education and training, could help provide person-centered interventions that enable a ''participatory person-centered model of care'' in a timely and effective manner. 48 Moreover, a recent systematic review 8 has identified that the Supportive Care Needs Survey 30, 31 would be suitable for use in routine clinical practice because this instrument identifies unmet supportive care needs and has demonstrated reliability and validity in men affected by prostate cancer.
Limitations
The qualitative methods were particularly useful in identifying the limitations within the current follow-up services, as described by patients in a main cancer center in Scotland. By purposive sampling of patients who had experienced varying times since diagnosis, age, socioeconomic status, number of existing comorbidities, we were able to explore some diversity in men's experiences, which was strength to the study. However, there were a few shortcomings, and one of which is the crosssectional design; hence, our knowledge is limited to a ''snapshot.'' Because of the population of men affected by prostate cancer increases and the need for monitoring and management, we need to understand how supportive care needs change over time, to enable healthcare professionals to target effective and appropriate intervention in a timely manner. A further limitation is that of retrospective memory recall bias in the assessment of supportive care needs. Retrospective questionnaires and interview techniques are prone to errors and biases as a result of autobiographical memory, because this places demands on participants to accurately recall their experiences (that is to say, eg, over the past month). 49, 50 Consequently, the ''real life'' validity of the data is unknown. However, this study is one of the first to detail the unmet supportive care needs as voiced by men affected by locally advanced or metastatic prostate cancer treated with hormone therapy in the United Kingdom.
n Conclusion
The study identified that men with prostate cancer treated with hormone therapy experienced a range of complex unmet supportive care needs. Our findings can inform translational research that aims to deliver a multimodal supportive care intervention tailored at the ''individual level of need.'' However, in the meantime, healthcare professionals are encouraged to reflect on these findings to ensure a holistic and person-centered care delivery, for each and individual man.
